Xconomy

OCTOBER 1, 2018

VelosBio, a biotech startup researching new cancer drugs, has raised $58 million in financing. VelosBio joined Johnson & Johnson’s JLABS @ San Diego incubator in January. The new VelosBio cash, a Series A round of financing, was led by Arix Bioscience (LSE: ARIX ) and Sofinnova Ventures.

San Diego 91

San Diego Incubator Class Study 91

Xconomy

APRIL 15, 2020

Some of the targets in cancer research are visible and well known, but they’re hard to hit with new drugs all the same. PIC Therapeutics is developing medicines aiming for one particularly elusive group of proteins, and the startup’s early research has attracted financial support from some prominent names in the life sciences industry.

Research 91

Research Invest Funding Develop 91

Xconomy

JULY 17, 2020

If it seems like biotech investments have defied the financial headwinds of the pandemic, maybe it’s because they have. In the second quarter, 16 of the top 25 largest early-stage venture capital deals were investments in life science companies. It’s the biotech sector’s largest proportion of the top 25.

Venture Capital 90

Venture Capital Invest Research Capital 90

Xconomy

APRIL 30, 2019

Vividion Therapeutics, a biotechnology company that launched in 2017 around discoveries made in Scripps Research Institute labs, has raised $82 million in financing. Nextech Invest, a Swiss investment firm that funds companies developing cancer therapeutics, led the Series B round of funding.

Research 87

Research Invest Funding Develop 87

Xconomy

FEBRUARY 15, 2017

For these reasons, fatty liver disease is often called a “silent disease,” says Ariel Feldstein, a gastroenterologist at the University of California San Diego. Feldstein has been studying the liver for nearly 20 years, and his research now forms the basis of a newly launched company called Jecure Therapeutics.

UCSD 64

UCSD Press San Diego Class 64

Xconomy

MARCH 13, 2018

Crinetics Pharmaceuticals , a San Diego biotech focused on developing new drugs for endocrine disorders and endocrine-related cancers, said today it has raised $63.5 million in a Series B financing led by Perceptive Advisors, the New York biotech fund. In a statement Tuesday, Crinetics said it plans.

San Diego 49

San Diego Research Funding Capital 49

Xconomy

APRIL 10, 2020

The coronavirus research is expected. Startups are raising money, and there is more financing on the way as investment firms close new funds. The COVID-19 pandemic has stopped enrollment in many clinical trials and postponed the start of others but there is still life in the life sciences sector.

Activity 103

Activity Research Invest Startup 103

Xconomy

OCTOBER 1, 2019

Biologists have been using artificially created DNA, produced through what’s known as chemical DNA synthesis, as a research tool for decades. Now, as demand for engineered DNA rises, a handful of startups are vying to become the go-to provider for researchers looking for improved versions of the DNA sequences.

San Diego 43

San Diego Research Writing Demand 43

socalTECH

DECEMBER 26, 2018

In my new role as the first executive director for the Alliance for Southern California Innovation, I spent a lot of time outside of my home turf of Pasadena -- visiting innovation nodes such as San Diego, Irvine, Riverside, Santa Barbara, Venice, Santa Monica, and others.

Southern California 113

Southern California SoCal Pasadena Riverside 113

Xconomy

AUGUST 17, 2016

Histogen, a San Diego-based regenerative medicine company with technology for growing skin cells and related products, said it has raised $6 million from an affiliate of Huapont Life Sciences, a healthcare products company based in Chongqing, China.

Invest 40

Invest San Diego Journal Technical Review 40

Xconomy

SEPTEMBER 19, 2019

The San Diego-based biotech came out of stealth mode Thursday with an announcement that it had raised a $46.4 million Series A financing round to fund the development of cancer drugs targeting tumors that have what’s known as extrachromosomal DNA.

San Diego 102

San Diego Funding Develop Development 102

Xconomy

FEBRUARY 2, 2017

A team of decorated academic chemists in San Diego have been working since 2014 on a biotech startup that aims to find new drugs faster. Vividion Therapeutics is launching with $50 million pledged from investment firms Arch Venture Partners and Versant Ventures. In an interview, Daniel (pictured) said that.

San Diego 40

San Diego Startup Guide Research 40

Xconomy

JUNE 22, 2016

Radicle, which takes its name from the botany term for the part of a plant embryo that develops into the primary root, was founded by a mix of agricultural investment and industry heavyweights. Before making an investment, Radicle says it screens technologies and can quickly vet and validate technologies through its farm connections.

Funding 68

Funding Research San Diego Incubator 68

Xconomy

SEPTEMBER 2, 2020

Research has yielded a crop of gastrointestinal disorder drug. Seattle-based Lumen turns spirulina into tiny factories that churn out therapeutic antibodies. Finrow says the Lumen technology overcomes many of the challenges of working with cyanobacteria. Read more » Reprints | Share: UNDERWRITERS AND PARTNERS.

Research 120

Research Startup Technology San Diego 120

Xconomy

OCTOBER 22, 2018

San Diego-based Qpex has raised $33 million to advance The Medicines Company’s (NASDAQ: MDCO ) old preclinical compounds toward human testing. The Medicines Company exited the infectious disease business last year when it sold three bacteria-fighting products to Melinta Therapeutics.

San Diego 86

San Diego Company Companies Develop 86

Xconomy

SEPTEMBER 23, 2019

Ivan Liachko turned postdoctoral research at the University of Washington into a company whose genomics tools are now found in laboratories researching human, animal, and plant health. His firm, Phase Genomics was one of the first startups to come out of UW’s genome sciences department. Some technologies developed in UW labs.

Incubator 111

Incubator Research Tool Startup 111

Xconomy

MAY 24, 2019

Eckelman is the company’s chief scientific officer and executive vice president of strategy; Deveraux is its executive vice president of early research. Read more » Reprints | Share: UNDERWRITERS AND PARTNERS.

Press 67

Press Research Funding Invest 67

Xconomy

APRIL 22, 2020

Drug research aiming to turn bacteria into microbiome therapies now spans programs aiming to address gut disorders, autism, cancer, and more. The start of a potentially big biomedical breakthrough is blooming within all of us.

Class 138

Class Study Research Report 138

Xconomy

OCTOBER 12, 2016

On Monday, nine startups began a 16-week program at Canopy San Diego , a new accelerator program for seed-stage companies developing new technologies, products, and services to support the legal cannabis industry. billion , according to ArcView Market Research. The ArcView Group is a partner in CanopyBoulder).

San Diego 40

San Diego Startup Southern California Invest 40

Xconomy

OCTOBER 26, 2018

In the biotech investment and research communities this week, much of the attention was turned to Europe.

Pricing 86

Pricing Conference Research Invest 86

Xconomy

SEPTEMBER 5, 2018

Los Angeles has long been in San Francisco’s shadow when it comes to life sciences investment. But a new venture capital firm led by industry veterans is trying to cast the City of Angels in a new light. Westlake Village BioPartners is launching today with $350 million in committed capital.

Westlake Village 73

Westlake Village Los Angeles Angel Venture Capital 73

Xconomy

APRIL 8, 2020

The cash, an upfront payment to Waltham, MA-based Arrakis, kicks off a research partnership set up to feed new drug candidates into the Roche pipeline.

Research 87

Research Tool Startup Technology 87

Xconomy

MARCH 22, 2018

For the first 50 years of its existence, Bose Corporation invested primarily in in-house research and development to produce its lineup of high-end headphones, speakers, and other audio technologies. The privately held company made its first investment in a startup in late 2015, and last year it officially launched a corporate venture.

Venture Capital 70

Venture Capital Patents Research Invest 70

Both Sides of the Table

APRIL 13, 2011

I owe ya’ a 20 minute call (or in person next time I’m in San Diego). Brad on blogging. How did you start blogging? “My A deep dive into the Foundry Group investment philosophy including an interesting discussion of their investing Themes. “… our lens is: Internet Software Companies anywhere in the U.S.

Venture Capital 288

Venture Capital Startup Technical Review Software Review 288

Xconomy

JULY 19, 2016

Synthorx, the San Diego synthetic biology startup that expanded the number of DNA base pairs with two synthetic nucleotides, said today it has raised $10 million in a Series B financing round led by RA Capital Management, the Boston life sciences hedge fund.

San Diego 40

San Diego Avalon Research Examples 40

Xconomy

AUGUST 8, 2016

It’s been less than a year since Needham, MA-based PTC (NASDAQ: PTC ) shelled out $65 million to acquire Vuforia, the augmented reality technology created by San Diego-based Qualcomm (NASDAQ: QCOM ). Vuforia’s headquarters has remained in San Diego, and Vuforia continues to operate four offices in Europe and Israel, Wright said.

San Diego 40

San Diego Mobile Examples .Net 40

Xconomy

MARCH 20, 2018

We’re recapping them very quickly here, and adding two reaction quotes we received from Carrie Morton, deputy director of the University of Michigan’s Mcity research facility and test bed, and Shahin Farshchi, a partner at Lux Capital, a Silicon Valley venture capital firm that has a number of investments in mobility companies.

Venture Capital 75

Venture Capital Research Mobile Capital 75

Xconomy

MAY 9, 2019

According to IPO research firm Renaissance Capital , 47 IPOs have priced so far this year across all sectors, down 27 percent compared to the same period in 2018. It will be hard to top last year’s flurry of biotech companies joining the public markets, but this week is shaping up to be the busiest for life science IPOs in recent memory.

Pricing 110

Pricing Research Capital Marketing 110

Xconomy

SEPTEMBER 13, 2016

MedCrypt, a healthtech cybersecurity startup founded near San Diego, has raised $750,000 in a seed financing round led by Safeguard Scientifics (NYSE: SFE ), a private equity fund in suburban Philadelphia that invests in healthcare, fintech, and digital media. 25 that it had uncovered “troubling cybersecurity flaws” in St.

San Diego 40

San Diego Startup Software Capital 40

Xconomy

DECEMBER 12, 2019

Nearly nine years ago Jeanne Loring and her colleagues at Scripps Research debuted a test that leveraged advances in genomics and data science to determine, without testing in animals, whether human stem cells were “pluripotent,” or able to become any type of cell in the body.

Research 96

Research San Diego Blogging Invest 96

Xconomy

FEBRUARY 15, 2017

The final numbers on 2016 fintech funding deals are in from New York-based research firm and investment database CB Insights, and venture capitalists seem to be cooling on the industry. billion in venture capital across 836 investments last year. Fintech has seen a frothy flood of. Read more » Reprints | Share:

Venture Capital 59

Venture Capital Report Research Activity 59

Xconomy

JUNE 13, 2019

The new Series B round will give San Francisco-based BlackThorn—a startup spun out of the Scripps Research Institute in 2013—the backing to run human tests of two experimental treatments. One, headed for Phase 2 testing by next year, is being developed for mood or anxiety disorders.

Tool 78

Tool Study Research Startup 78

Xconomy

JANUARY 13, 2019

trillion annually, according to IHL, a Tennessee firm that specializes in retail and hospitality research. “Something like one out of eight or 10 items is typically not in stock.” Inaccurate inventory costs retailers $1.1 Pensa, an Austin startup. Read more » Reprints | Share: UNDERWRITERS AND PARTNERS.

Research 109

Research Sales Startup Artificial Inteligence 109

Xconomy

APRIL 16, 2019

Insitro announced Tuesday that Gilead (NASDAQ: GILD ) will pay the South San Francisco-based startup $15 million to kick off a three-year research collaboration. The deal calls for Insitro to create disease models for NASH in hopes of finding targets. Read more » Reprints | Share: UNDERWRITERS AND PARTNERS.

Artificial Inteligence 100

Artificial Inteligence Research Startup Company 100

Xconomy

NOVEMBER 6, 2019

AstraZeneca says it will establish centers for drug research and artificial intelligence development in China. The pharmaceutical giant has also set up a $1 billion fund to foster biotech innovation in that country.

Artificial Inteligence 87

Artificial Inteligence Funding Research Sites 87

Xconomy

JUNE 28, 2018

The Series D round included investments from previous BitSight backers Menlo Ventures, GGV Capital, and Singtel Innov8. The new funding brings BitSight’s total venture capital haul to $155.

Venture Capital 55

Venture Capital Equity Research Capital 55

Xconomy

OCTOBER 5, 2018

The idea of harnessing the immune system to treat cancer has sparked billions of dollars in research, led to a vast matrix of clinical trials, and started to change the way how several cancers are treated. Now the some of the field’s founding research has been recognized with one of the highest honors in science.

Research 65

Research Ideas San Diego Organization 65